Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 164

The DOI matches its Crossref record.

A Double‐blind Placebo‐controlled Prophylactic Study of Flunarizine (Sibelium®) in Migraine

Louis, Paul·1981·Headache: The Journal of Head and Face Pain

Abstract

SYNOPSIS The potential prophylactic value of a daily dose of 10 mg flunarizine, a calcium antagonist with anti‐vasospastic properties was studied in a 3‐month double‐blind placebo‐controlled trial in 58 migraineurs. With an almost perfect mutual correlation, both the patients' overall appreciation of the treatment and the reduction of migraine attacks proved flunarizine to be effective (p<0.001). Half of the flunarizine‐patients considered the treatment certainly beneficial in contrast to none of the placebo‐patients. In 21 of the 29 flunarizine‐patients the attack rate was lower than expected in 20 of the 29 controls it was not. Younger patients appeared to respond better to the treatment. Flunarizine displayed a gradually increasing effect; during the third month 83% of the treated patients were completely attack‐free. The drug did not appear to influence the severity and duration of attacks, however. Treatment was very well tolerated. Flunarizine, therefore, appears to be a very suitable agent for migraine prophylaxis but it should be given for more than two months in order to obtain full effectiveness with this dosage.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1526-4610.1981.hed2106235.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 164

Metadata

Authors
Louis, P.
Venue
Headache: The Journal of Head and Face Pain
Publisher
Wiley
Published
1981-11
Volume
21
Issue
6
Pages
235-239
ISSN
  • 0017-8748 (ISSN-L)
  • 1526-4610
OpenAlex
W2085466165
Cited by
164
References
0
FWCI
6.73
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Double‐blind Placebo‐controlled Prophylactic Study of Flunarizine (Sibelium®) in Migraine. https://app.cochat.ai/papers/10.1111/j.1526-4610.1981.hed2106235.x
The paper
Louis, P. (1981). A Double‐blind Placebo‐controlled Prophylactic Study of Flunarizine (Sibelium®) in Migraine. Headache: The Journal of Head and Face Pain. https://doi.org/10.1111/j.1526-4610.1981.hed2106235.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.